Zafirlukast Tablet, Film Coated
Product Images NDC 68084-059

5 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 68084-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg Zafirlukast Tablets Blister

20 mg Zafirlukast Tablets Blister
Zafirlukast 20 mg film-coated oral tablets by American Health Packaging. The image shows multiple identical labels with the product name, dosage strength, tablet form, labeler information, placeholder lot number, and expiration date, along with barcodes on each label.*
FDA Label Image

20 mg Zafirlukast Tablets Carton (20 mg Zafirlukast Tablets Carton)

20 mg Zafirlukast Tablets Carton (20 mg Zafirlukast Tablets Carton)
Drug label text panel for Zafirlukast Tablets, 20 mg, containing 30 tablets (3 blister packs of 10 each). Includes storage instructions, pharmacy dispensing note, safety warnings, manufacturer and distributor information for American Health Packaging.*
FDA Label Image

8cc7d663 Fb49 459e E053 2995a90aeabd

8cc7d663 Fb49 459e E053 2995a90aeabd
Zafirlukast 20 mg film-coated oral tablet. The tablet is white and round, embossed with 'R' on one side and '626' on the other. Manufactured by American Health Packaging.*
FDA Label Image

Mean Beta2 (agonist use (puffs/day))

Mean Beta2 (agonist use (puffs/day))
A line graph depicting mean beta-2 agonist use in puffs per day over a 14-week trial period. The graph compares placebo, Zafirlukast 20 mg twice daily, and cromolyn sodium 1600 mcg four times a day treatments, showing adjusted treatment means on the vertical axis and trial weeks on the horizontal axis.*
FDA Label Image

Zafirlukast Structural Formula (Image 02)

Zafirlukast Structural Formula (Image 02)
Chemical structure of the active ingredient Zafirlukast, depicting its molecular arrangement with various functional groups and rings typically seen in its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.